1	3 Female patients of non-childbearing potential by reason of surgery radiation or menopause at least one year post onset female patients of childbearing potential who are using at least two approved methods of contraception such as an intrauterine device IUD implant oral contraceptive or barrier method|oral contraceptive[267,285]||intrauterine device[235,254]||||||||2821|2821|oral contraceptive
2	plus spermicide Use of a low-dose estrogen oral contraceptive alone will not be permitted Female patients of childbearing potential must agree to continue to use two approved methods of contraception through the follow-up visit or for 30 days after their final dose of study medication whichever is|oral contraceptive[347,365]|||||||30 days[539,546]|||2821|2821|oral contraceptive
2	plus spermicide Use of a low-dose estrogen oral contraceptive alone will not be permitted Female patients of childbearing potential must agree to continue to use two approved methods of contraception through the follow-up visit or for 30 days after their final dose of study medication whichever is|estrogen[338,346]|||low - dose[329,337]|||||||4100|4100|estrogens
2	plus spermicide Use of a low-dose estrogen oral contraceptive alone will not be permitted Female patients of childbearing potential must agree to continue to use two approved methods of contraception through the follow-up visit or for 30 days after their final dose of study medication whichever is|spermicide[309,319]||||||||||9969|9969|spermicide
